切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - PKB - 5-HT7 Receptors - Sphingosine kinases (SphKs) - 5-HT receptor

9 件产品

每页
清除全部
  1. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  2. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  3. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  4. K145
    B1298 K145
    Target: Sphingosine kinases (SphKs)
    Summary: SphK2抑制剂
      Soluble in DMSO
  5. SKI II
    B2226 SKI II
    Target: Sphingosine kinases (SphKs)
    Summary: 鞘氨醇激酶(SK)抑制剂
      ≥15.15 mg/mL
      insoluble in H2O
  6. SB 203580
    A8254 SB 203580
     9 Citation
    Target: p38|PKB
    Summary: P38 MAP激酶抑制剂
      ≥18.872 mg/mL
      insoluble in H2O
  7. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  8. Quetiapine
    A3744 Quetiapine
    中文名: 喹硫平
    Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptor
    Summary: 多巴胺受体拮抗剂
      ≥19.18 mg/mL
      insoluble in H2O
  9. PF-543
    A3717 PF-543
     1 Citation
    Target: Sphingosine kinases (SphKs)
    Summary: SphK1选择性抑制剂
      ≥23.3 mg/mL
      insoluble in H2O

9 件产品

每页